Anti-Membrane Protein Antibody Discovery Service by Yeast Display

Services Workflow Features Published Data Related Services Introduction

Anti-Membrane Protein Antibody Discovery and Evaluation

Do you experience extended drug development durations along with problems in protein expression and purification, and obstacles in antibody development? The anti-membrane protein antibody discovery and evaluation service provided by Creative Biolabs enables faster drug discovery and the development of precise antibodies by utilizing sophisticated yeast surface display technology.

Fig 1. A picture demonstrating membrane protein. (Creative Biolabs Authorized)

Our anti-membrane protein antibody discovery and evaluation service provides top-tier outcomes with its adaptable and client-tailored methodology. Our approach integrates state-of-the-art yeast display technology with customized solutions to address essential challenges in membrane protein antibody discovery.

We offer additional customization options to boost the flexibility of your projects.

Improved Display Systems	Novel Screening Methods	Cell-Based Screening
We continuously optimize our yeast display platform, refining fusion protein strategies and developing methods to monitor display levels, ensuring more efficient and accurate screening.	We employ advanced screening techniques to maximize the efficiency of isolating high-affinity, target-specific antibodies, accelerating the discovery process.	We enable antibody screening against membrane proteins in their native conformation, leveraging whole-cell systems to improve success rates - especially for challenging targets like GPCRs.

Workflow

Our service is designed to offer efficiency, reliability, and flexibility, seamlessly aligning with your project needs.

01Required Starting Materials

Target Information: Sequence, structural data
Source: Cell lines, purified protein, membrane fractions
Application: Intended use of the antibody

02Membrane Protein Expression

Expression in yeast/mammalian cells
Solubilization & stabilization (if required)
Retaining native conformation
whole cells expressing the target protein

03Antibody Library Construction

Custom library design (species-specific: human/mouse/camelids/synthetic)
Diverse antibody fragments: scFv, Fab, VHH
Library size optimization based on project scope

04Yeast Display Library Screening

High-throughput sorting (MACS / FACS)
Cell-based screening
Iterative selection for affinity enhancement

05Antibody Characterization

Binding analysis
Specificity & Epitope mapping
Functional validation (cell-based assays)

06Optional Antibody Engineering

Affinity Maturation: Mutagenesis & evolution
Humanization: Reduce immunogenicity
Format Optimization: scFv, Fab, BsAbs, ADC

07Final Deliverables

Comprehensive report: Experimental workflow, screening data, validation results
Antibody sequences & binding data

08Further Supports

Further antibody optimization & development

Why Choose Us?

Native Membrane Protein Presentation

Retains protein structure and function for accurate screening.

Membrane Protein Compatibility

Works with GPCRs, ion channels, transporters, and other membrane proteins.

Flexibility with Target Types

Supports diverse targets, from soluble proteins to complex formats.

Efficient Library Diversification

Large, diverse antibody libraries for high variability and broad epitope coverage.

High-Throughput Screening

Rapid identification of high-affinity binders using FACS and flow cytometry.

Cost-Effectiveness and Scalability

Affordable, scalable solutions for small to large-scale projects.

Rapid Affinity Maturation

Fast optimization of binding strength and specificity via directed evolution.

Streamlined Project Process

Efficient, seamless process from discovery to final deliverables.

Published Data

Fig 2. A schematic representation of the screening procedure. (OA Literature). Fig 2. Yeast surface display and screening strategies.¹

The study investigates how yeast display technology facilitates the discovery of antibodies against membrane proteins. The authors compare two antibody screening methods: cell-based biopanning and FACS using solubilized targets. The two antibody selection methods proved successful in isolating clones that bind to the target. These antibody discovery techniques function as a swifter and more effective alternative to conventional methods which may accelerate therapeutic research for conditions.

Related Services

We offer an extensive range of yeast display-based antibody discovery services designed to support your research and therapeutic initiatives, including but not limited to:

Introduction

Membrane proteins control cellular functions and function as vital elements in cancers and neurological and autoimmune diseases. Traditional antibody discovery methods encounter significant difficulties with membrane proteins because their intricate three-dimensional structures and hydrophobic characteristics make them challenging. Yeast display stands as a rapid and high-throughput method for identifying specific antibodies which could selectively target membrane proteins of interest thereby addressing these challenges.

Are you seeking to enhance your research capabilities through advanced antibody discovery platform? Discover how our yeast display platform caters to your membrane protein targeting and antibody development requirements by reaching out to us today.

Reference

Huang, Aric,et al. "Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries." Antibodies 11.2 (2022): 39. Under Open Access license CC BY 4.0, without modification.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: